Nutrinia

Nutrinia is a neonatology company dedicated to developing drugs to treat rare gastrointestinal diseases. Our current product under development is an oral insulin formulation that enhances the adaptability and recovery of infants' intestines. At Nutrinia, we believe that science is best used to improve lives, particularly those of the most vulnerable populations, while also developing unique therapies for patients with intestinal failure.